FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016099575> ?p ?o ?g. }

• W2016099575 endingPage "145" @default.
• W2016099575 startingPage "143" @default.
• W2016099575 abstract "Clinical EndocrinologyVolume 83, Issue 1 p. 143-145 Letter to the Editor Long-lasting complete remission after therapy with temozolomide in two patients with macrocorticotropinoma causing Cushing's disease Oscar D. Bruno, Oscar D. Bruno [email protected] Fundación de Endocrinología y Estudios Metabólicos y Endocrinos, Buenos Aires, ArgentinaSearch for more papers by this authorLea Juárez-Allen, Lea Juárez-Allen Fundación de Endocrinología y Estudios Metabólicos y Endocrinos, Buenos Aires, ArgentinaSearch for more papers by this authorSilvia B. Christiansen, Silvia B. Christiansen Pathology Laboratory, Hospital Italiano, Buenos Aires, ArgentinaSearch for more papers by this authorKarina Danilowicz, Karina Danilowicz Division of Endocrinology, Hospital de Clinicas, Buenos Aires, ArgentinaSearch for more papers by this author Oscar D. Bruno, Oscar D. Bruno [email protected] Fundación de Endocrinología y Estudios Metabólicos y Endocrinos, Buenos Aires, ArgentinaSearch for more papers by this authorLea Juárez-Allen, Lea Juárez-Allen Fundación de Endocrinología y Estudios Metabólicos y Endocrinos, Buenos Aires, ArgentinaSearch for more papers by this authorSilvia B. Christiansen, Silvia B. Christiansen Pathology Laboratory, Hospital Italiano, Buenos Aires, ArgentinaSearch for more papers by this authorKarina Danilowicz, Karina Danilowicz Division of Endocrinology, Hospital de Clinicas, Buenos Aires, ArgentinaSearch for more papers by this author First published: 22 January 2015 https://doi.org/10.1111/cen.12727Citations: 5 Presented in part at The Endocrine Society Annual Meeting, Phoenix, AZ, 2013. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Syro, L.V., Uribe, H., Penagos, L.C. et al. (2006) Antitumour effects of temozolomide in a man with a large, invasive prolactin-producing pituitary neoplasm. Clinical Endocrinology (Oxford) 65, 552–553. 2McCormack, A.I., Wass, J.A. & Grossman, A.B. (2011) Aggressive pituitary tumours: the role of temozolomide and the assessment of MGMT status. European Journal of Clinical Investigation, 41, 1133–1148. 3Annamalai, A.K., Dean, A.F., Kandasamy, N. et al. (2012) Temozolomide responsiveness in aggressive corticotroph tumours: a case report and review of the literature. Pituitary, 15, 276–287. 4Zacharia, B.E., Gulati, A.P., Bruce, J.N. et al. (2014) High response rates and prolonged survival in patients with corticotroph pituitary tumours and refractory Cushing disease from capecitabine and temozolomide (CAPTEM): a case series. Neurosurgery, 74, E447–E455. 5Hirohata, T., Asano, K., Ogawa, Y. et al. (2013) DNA mismatch repair protein (MSH6) correlated with the responses of atypical pituitary adenomas and pituitary carcinomas to temozolomide: the national cooperative study by the Japan Society for Hypothalamic and Pituitary Tumours. Journal of Clinical Endocrinology and Metabolism, 98, 1130–1136. Citing Literature Volume83, Issue1July 2015Pages 143-145 ReferencesRelatedInformation" @default.
• W2016099575 created "2016-06-24" @default.
• W2016099575 creator A5012479141 @default.
• W2016099575 creator A5014132526 @default.
• W2016099575 creator A5015141965 @default.
• W2016099575 creator A5076108333 @default.
• W2016099575 date "2015-02-12" @default.
• W2016099575 modified "2023-10-09" @default.
• W2016099575 title "Long‐lasting complete remission after therapy with temozolomide in two patients with macrocorticotropinoma causing Cushing's disease" @default.
• W2016099575 cites W1626154384 @default.
• W2016099575 cites W1983683682 @default.
• W2016099575 cites W2062317084 @default.
• W2016099575 cites W2139003932 @default.
• W2016099575 cites W2330508951 @default.
• W2016099575 doi "https://doi.org/10.1111/cen.12727" @default.
• W2016099575 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25611185" @default.
• W2016099575 hasPublicationYear "2015" @default.
• W2016099575 type Work @default.
• W2016099575 sameAs 2016099575 @default.
• W2016099575 citedByCount "6" @default.
• W2016099575 countsByYear W20160995752015 @default.
• W2016099575 countsByYear W20160995752016 @default.
• W2016099575 countsByYear W20160995752018 @default.
• W2016099575 countsByYear W20160995752020 @default.
• W2016099575 countsByYear W20160995752023 @default.
• W2016099575 crossrefType "journal-article" @default.
• W2016099575 hasAuthorship W2016099575A5012479141 @default.
• W2016099575 hasAuthorship W2016099575A5014132526 @default.
• W2016099575 hasAuthorship W2016099575A5015141965 @default.
• W2016099575 hasAuthorship W2016099575A5076108333 @default.
• W2016099575 hasBestOaLocation W20160995751 @default.
• W2016099575 hasConcept C126322002 @default.
• W2016099575 hasConcept C142362112 @default.
• W2016099575 hasConcept C15708023 @default.
• W2016099575 hasConcept C187212893 @default.
• W2016099575 hasConcept C71924100 @default.
• W2016099575 hasConceptScore W2016099575C126322002 @default.
• W2016099575 hasConceptScore W2016099575C142362112 @default.
• W2016099575 hasConceptScore W2016099575C15708023 @default.
• W2016099575 hasConceptScore W2016099575C187212893 @default.
• W2016099575 hasConceptScore W2016099575C71924100 @default.
• W2016099575 hasIssue "1" @default.
• W2016099575 hasLocation W20160995751 @default.
• W2016099575 hasLocation W20160995752 @default.
• W2016099575 hasOpenAccess W2016099575 @default.
• W2016099575 hasPrimaryLocation W20160995751 @default.
• W2016099575 hasRelatedWork W1506200166 @default.
• W2016099575 hasRelatedWork W1995515455 @default.
• W2016099575 hasRelatedWork W2048182022 @default.
• W2016099575 hasRelatedWork W2080531066 @default.
• W2016099575 hasRelatedWork W2604872355 @default.
• W2016099575 hasRelatedWork W2748952813 @default.
• W2016099575 hasRelatedWork W2899084033 @default.
• W2016099575 hasRelatedWork W3031052312 @default.
• W2016099575 hasRelatedWork W3032375762 @default.
• W2016099575 hasRelatedWork W3108674512 @default.
• W2016099575 hasVolume "83" @default.
• W2016099575 isParatext "false" @default.
• W2016099575 isRetracted "false" @default.
• W2016099575 magId "2016099575" @default.
• W2016099575 workType "article" @default.